Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Innovative MedTech Inc. (IMTH)
USD0.00
0.00 (-6.67%)
US OTC Healthcare Medical - Instruments & Supplies
Address
2310 York Street 60406
Blue Island, IL, US
Blue Island, IL, US
CEO
Michael Jordan Friedman
Website
innovativemedtechinc.com
IPO
2007-05-08
CIK 1331612 ISIN US45782W1080
Description
Innovative MedTech Inc., an organization operating across the United States via its various subsidiaries, focuses on delivering health and wellness solutions. A primary component of its business involves the operation and franchising of adult day care centers. These facilities offer a comprehensive range of services, including professional nursing assistance, personal grooming amenities (salon services), nutritional meal provisions, and diverse recreational and social engagement activities designed to enhance participants' well-being and foster community. The company maintains a network of 29 locations in total, with two directly owned and managed by the corporation, and the other twenty-seven operating under franchise agreements. Established in 2005, the company was initially known as Fresh Harvest Products, Inc., before officially adopting its current name, Innovative MedTech Inc., in March 2021. Its corporate headquarters are situated in Blue Island, Illinois.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.00
0.00 (-6.67%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
340
Beta
-0.94
Float Shares
36.51M
Free Float %
61.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -29.41% | -29.41% | -29.41% | -20.00% | -99.00% | -95.40% | -99.68% | -99.78% | -99.92% | -99.88% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.00
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-272.27
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
1 / 10
No MOAT
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%-100.0% Q2'25: -100.0% (vs Q2'24)
-
EPS growth Medical - Instruments & Supplies: +16.3%+109.1% ★ Q2'25: +129.4% (vs Q2'24)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%—
-
EBIT margin Medical - Instruments & Supplies: +13.5%—
-
ROIC Medical - Instruments & Supplies: +6.0%— Q2'25: -3.8% (vs Q2'24)
-
Share dilution Medical - Instruments & Supplies: +0.1%+71.3% Q2'25: +71.2% (vs Q2'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×-0.24× Q2'25: 41.32× (vs Q2'24)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-04-27 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
2.02M
OE per share TTM
0.05
Owner's Yield
4,111.45%
Maintenance CapEx ratio
8.12%
Maint CapEx / Avg PPE
59.9%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
3.75M
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+3,750,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-17 | Friedman Michael Jordan | Director / Officer / 10% Owner | J-Other | A | Common Stock | 6,500,000 | 0.01 | 32.5K | 9,918,607 | I | ↗ |
| 2024-01-15 | Friedman Michael Jordan | Director / Officer / 10% Owner | A-Award | A | Option | 3,750,000 | 0.50 | 1.88M | 5,150,000 | — | ↗ |
| 2022-05-02 | Griff Merle | — | — | D | Option | 150,000 | 2.00 | 300.0K | 0 | — | ↗ |
| 2022-05-02 | Friedman Michael Jordan | — | P-Purchase | A | Option | 350,000 | 6.00 | 2.10M | 1,400,000 | — | ↗ |
| 2022-04-26 | Dovner Eddie | Director | J-Other | A | Common Stock | 2,460,012 | 0.05 | 123.0K | 2,460,012 | — | ↗ |
| 2021-03-25 | Friedman Michael Jordan | — | — | I | Common Stock | 0 | 0.00 | — | 3,418,607 | — | ↗ |
| 2021-03-25 | Everhardt Charles | — | J-Other | A | Common Stock | 114,244 | 0.05 | 5.7K | 2,574,256 | — | ↗ |
| 2021-03-25 | Dovner Eddie | — | — | I | Series A Preferred Stock | 0 | 0.00 | — | 100,542 | — | ↗ |
| 2021-03-09 | Friedman Michael Jordan | — | J-Other | A | Series A Preferred Stock | 4,240 | 0.00 | 0.42 | 4,240 | — | ↗ |
| 2012-10-01 | Odintz Jay | Director / 10% Owner | C-Conversion | A | Common stock | 153,333,333 | 46,000.00 | 7.05T | 164,333,333 | — | ↗ |
| 2012-10-01 | Friedman Michael Jordan | Director / Officer | C-Conversion | A | Common Stock | 413,333,333 | 0.00 | — | 456,928,040 | — | ↗ |
| 2011-09-16 | Odintz Jay | Director | C-Conversion | A | Common Stock | 100,000 | 0.00 | — | 10,000,000 | — | ↗ |
| 2011-09-16 | Friedman Michael Jordan | Director / Officer | C-Conversion | A | Common Stock | 36,824,400 | 0.00 | — | 36,824,400 | — | ↗ |
| 2011-09-16 | Friedman Arthur | — | C-Conversion | A | Common Stock | 18,021,000 | 0.00 | — | 18,021,000 | — | ↗ |
| 2011-09-16 | Cingari Dominick M | Director | C-Conversion | A | Common Stock | 100,000 | 0.00 | — | 10,000,000 | — | ↗ |
| 2011-03-04 | Odintz Jay | Director | P-Purchase | A | Series A Convertible Preferred Stock | 100,000 | 0.00 | — | 100,000 | — | ↗ |
| 2011-03-04 | Friedman Michael Jordan | Director / Officer | P-Purchase | A | Series A Convertible Preferred Stock | 368,244 | 0.00 | — | 368,244 | — | ↗ |
| 2011-03-04 | Friedman Arthur | — | J-Other | A | Series A Convertible Preferred Stock | 80,460 | 0.00 | — | 80,460 | — | ↗ |
| 2011-03-04 | Cingari Dominick M | Director | P-Purchase | A | Series A Convertible Preferred Stock | 100,000 | 0.00 | — | 100,000 | — | ↗ |
| 2010-01-27 | Friedman Michael Jordan | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 0.03 | 1.3K | 6,770,307 | — | ↗ |
| 2009-04-01 | Odintz Jay | Director | A-Award | A | Common Stock | 700,000 | 0.00 | 70.00 | 800,000 | — | ↗ |
| 2008-03-10 | Roberts Marcia | 10% Owner | P-Purchase | A | Common stock | 5,000,000 | 0.00 | — | 7,450,000 | — | ↗ |
| 2008-03-10 | Friedman Arthur | 10% Owner | S-Sale | D | Common Stock | 5,000,000 | 0.00 | — | 824,000 | — | ↗ |
| 2008-02-14 | Friedman Arthur | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 5,824,000 | — | ↗ |
| 2007-12-07 | Odintz Jay | Director | A-Award | A | Common Stock | 100,000 | 0.00 | 10.00 | 100,000 | — | ↗ |
| 2007-01-19 | Cingari Dominick M | Director / Officer | A-Award | A | Common Stock | 500,000 | 0.01 | 5.0K | 2,200,000 | — | ↗ |
| 2006-02-06 | Roberts Marcia | 10% Owner | A-Award | A | Common Stock | 700,000 | 0.01 | 7.0K | 2,450,000 | — | ↗ |
| 2006-02-06 | Illuminate, Inc. | 10% Owner | A-Award | A | Common Stock | 743,853 | 0.01 | 7.4K | 4,013,810 | — | ↗ |
| 2006-02-06 | Friedman Michael Jordan | Director / Officer / 10% Owner | A-Award | A | Common Stock | 1,170,000 | 0.01 | 11.7K | 4,170,000 | — | ↗ |
| 2006-02-06 | Cingari Dominick M | Director / Officer | A-Award | A | Common Stock | 200,000 | 0.01 | 2.0K | 1,200,000 | — | ↗ |
| 2006-02-01 | Roberts Marcia | 10% Owner | A-Award | A | Common Stock | 1,668,333 | 0.01 | 16.7K | 1,750,000 | — | ↗ |
| 2006-02-01 | Illuminate, Inc. | 10% Owner | A-Award | A | Common Stock | 3,104,425 | 0.00 | 310.44 | 3,269,957 | — | ↗ |
| 2006-02-01 | Friedman Michael Jordan | Director / Officer / 10% Owner | A-Award | A | Common Stock | 2,886,000 | 0.01 | 28.9K | 3,000,000 | — | ↗ |
| 2006-02-01 | Cingari Dominick M | Director / Officer | A-Award | A | Common Stock | 966,667 | 0.01 | 9.7K | 1,000,000 | — | ↗ |
| 2006-02-01 | Bodine A William | Director / Officer | A-Award | A | Common Stock | 261,188 | 0.01 | 2.6K | 266,273 | — | ↗ |
| 2005-12-16 | Roberts Marcia | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 81,667 | — | ↗ |
| 2005-12-16 | Odintz Jay | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2005-12-16 | Illuminate, Inc. | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 165,532 | — | ↗ |
| 2005-12-16 | Friedman Michael Jordan | Director / Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 114,000 | — | ↗ |
| 2005-12-16 | Cingari Dominick M | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 33,333 | — | ↗ |
| 2005-12-16 | Bodine A William | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 5,085 | — | ↗ |
| 2005-05-01 | Verdiramo Vincent L | Director / Officer | I-Discretionary | D | Common Stock | 900,000 | 0.00 | — | 100,000 | — | ↗ |
| 2005-04-21 | Verdiramo Vincent L | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 1,000,000 | — | ↗ |
Executive team
Top executives
Shares Outstanding
59.84M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Michael Jordan Friedman | Chief Executive Officer, President, Chief Financial Officer & Director | 150.0K | male |
ESG Rating
ESG Score History MEDICAL - INSTRUMENTS & SUPPLIES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IMTH
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
